Metastatic breast cancer diagnoses are rising in U.S. women, especially in younger age groups and racial minorities, as ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

What started as a routine overnight trip to Edmonton in 2015 turned into a life-altering journey for Lianne Mantla-Look, a ...

Cancer patient and Illinois State University graduate Moji Kalantari is developing an app aimed at creating communities among ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

Pfizer, facing increasing pressure from Novartis, is touting a Phase III win for Ibrance as the first clinical evidence supporting the CDK4/6 inhibitor class’ use in patients with a specific type of ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in over-the-counter Rogaine. The prescription treatment is known, however, to dilate blood ...

The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

a population that represents 10% of breast cancer patients. Although not a game-changer for Pfizer, the data could could help ...